M&T Bank’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $465K | Sell |
|
|||||
|
2025
Q2 | $550K | Buy |
|
|||||
|
2025
Q1 | $469K | Sell |
|
|||||
|
2024
Q4 | $952K | Buy |
|
|||||
|
2024
Q3 | $651K | Sell |
|
|||||
|
2024
Q2 | $826K | Sell |
|
|||||
|
2024
Q1 | $854K | Sell |
|
|||||
|
2023
Q4 | $894K | Sell |
|
|||||
|
2023
Q3 | $814K | Sell |
|
|||||
|
2023
Q2 | $943K | Sell |
|
|||||
|
2023
Q1 | $1.06M | Sell |
|
|||||
|
2022
Q4 | $1.39M | Buy |
|
|||||
|
2022
Q3 | $1.08M | Sell |
|
|||||
|
2022
Q2 | $294K | Buy |
|
|||||
|
2022
Q1 | $248K | Buy |
|
|||||
|
2021
Q4 | $218K | Sell |
|
|||||
|
2021
Q3 | $274K | Sell |
|
|||||
|
2021
Q2 | $278K | Buy |
|
|||||
|
2021
Q1 | $277K | Sell |
|
|||||
|
2020
Q4 | $289K | Sell |
|
|||||
|
2020
Q3 | $294K | Buy |
|
|||||
|
2020
Q2 | $351K | Sell |
|
|||||
|
2020
Q1 | $291K | Buy |
|
|||||
|
2019
Q4 | $355K | Sell |
|
|||||
|
2019
Q3 | $313K | Buy |
|
|||||
|
2019
Q2 | $286K | Buy |
|
|||||
|
2019
Q1 | $285K | Buy |
|
|||||
|
2018
Q4 | $214K | Sell |
|
|||||
|
2018
Q3 | $380K | Buy |
|
|||||
|
2018
Q2 | $278K | Buy |
|
|||||
|
2018
Q1 | $235K | Buy |
|
|||||
|
2017
Q4 | $202K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $358K | Buy |
|
|||||
|
2016
Q2 | $210K | Sell |
|
|||||
|
2016
Q1 | $262K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $312K | Sell |
|
|||||
|
2015
Q1 | $269K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1K | Buy |
|